Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Caligiuri A, Cannito S, Antonaci C, Colombatto S, Pinzani M, Parola M
Università degli Studi di Torino, Dip Medicina e Oncologia Sperimentale, C so Raffaello 30, 10125 Torino, Italy.
Gut. 2006 Jan;55(1):90-7. doi: 10.1136/gut.2005.069633. Epub 2005 Jul 24.
Activated myofibroblast-like cells, originating from hepatic stellate cells (HSC/MFs) or other cellular sources, play a key profibrogenic role in chronic liver diseases (CLDs) that, as suggested by studies in animal models or rat HSC/MFs, may be modulated by reactive oxygen intermediates (ROI). In this study, human HSC/MFs, exposed to different levels of superoxide anion (O(2)(.-)) and, for comparison, hydrogen peroxide (H(2)O(2)), were analysed in terms of cytotoxicity, proliferative response, and migration.
Cultured human HSC/MFs were exposed to controlled O(2)(.-) generation by hypoxanthine/xanthine oxidase systems or to a range of H(2)O(2) concentrations. Induction of cell death, proliferation, and migration were investigated using morphology, molecular biology, and biochemical techniques.
Human HSC/MFs were shown to be extremely resistant to induction of cell death by O(2)(.-) and only high rates of O(2)(.-) generation induced either necrotic or apoptotic cell death. Non-cytotoxic low levels of O(2)(.-), able to upregulate procollagen type I expression (but not tissue inhibitor of metalloproteinase 1 and 2), stimulated migration of human HSC/MFs in a Ras/extracellular regulated kinase (ERK) dependent, antioxidant sensitive way, without affecting basal or platelet derived growth factor (PDGF) stimulated cell proliferation. Non-cytotoxic levels of H(2)O(2) did not affect Ras/ERK or proliferative response. A high rate of O(2)(.-) generation or elevated levels of H(2)O(2 )induced cytoskeletal alterations, block in motility, and inhibition of PDGF dependent DNA synthesis.
Low non-cytotoxic levels of extracellularly generated O(2)(.-) may stimulate selected profibrogenic responses in human HSC/MFs without affecting proliferation.
源自肝星状细胞(HSC/MFs)或其他细胞来源的活化肌成纤维细胞样细胞在慢性肝病(CLDs)中发挥关键的促纤维化作用,动物模型或大鼠HSC/MFs的研究表明,其可能受活性氧中间体(ROI)调节。在本研究中,对暴露于不同水平超氧阴离子(O(2)(.-))以及作为对照的过氧化氢(H(2)O(2))的人HSC/MFs进行了细胞毒性、增殖反应和迁移方面的分析。
将培养的人HSC/MFs暴露于次黄嘌呤/黄嘌呤氧化酶系统控制产生的O(2)(.-)或一系列H(2)O(2)浓度下。使用形态学、分子生物学和生化技术研究细胞死亡、增殖和迁移的诱导情况。
人HSC/MFs对O(2)(.-)诱导的细胞死亡表现出极强的抗性,只有高生成率的O(2)(.-)才会诱导坏死或凋亡性细胞死亡。非细胞毒性的低水平O(2)(.-)能够上调I型前胶原表达(但不影响金属蛋白酶组织抑制剂1和2),以一种依赖Ras/细胞外调节激酶(ERK)且对抗氧化剂敏感的方式刺激人HSC/MFs迁移,而不影响基础或血小板衍生生长因子(PDGF)刺激的细胞增殖。非细胞毒性水平的H(2)O(2)不影响Ras/ERK或增殖反应。高生成率的O(2)(.-)或升高的H(2)O(2)水平会诱导细胞骨架改变、运动受阻以及抑制PDGF依赖性DNA合成。
细胞外产生的低非细胞毒性水平的O(2)(.-)可能刺激人HSC/MFs中特定的促纤维化反应而不影响增殖。